Literature DB >> 33887806

The Future of Quality Improvement for Cirrhosis.

Elliot B Tapper1, Neehar D Parikh1.   

Abstract

Cirrhosis has a significant and growing impact on public health and patient-reported outcomes (PROs). The increasing burden of cirrhosis has led to an emphasis on the quality of care with the goal of improving overall outcomes in this high-risk population. Existing evidence has shown the significant gaps in quality across process measures (eg, hepatocellular carcinoma screening), highlighting the need for consistent measurement and interventions to address the gaps in quality care. This multistep process forms the quality continuum, and it depends on clearly defined process measures, real-time quality measurement, and generalizable evaluative methods. Herein we review the current state of quality care in cirrhosis across the continuum with a focus on process measurement methodologies, developments in PRO evaluation on quality assessment, practical examples of quality improvement initiatives, and the recent emphasis placed on the value of primary prevention.
Copyright © 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2021        PMID: 33887806      PMCID: PMC8487907          DOI: 10.1002/lt.26079

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   6.112


  58 in total

1.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

2.  Improving management of oesophageal varices in patients with cirrhosis.

Authors:  Rachel Wundke; Rosalie Altus; Jayne Sandford; Alan Wigg
Journal:  Qual Saf Health Care       Date:  2010-07-29

3.  Quality Measures, All-Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis.

Authors:  Marina Serper; David E Kaplan; Justine Shults; Peter P Reese; Lauren A Beste; Tamar H Taddei; Rachel M Werner
Journal:  Hepatology       Date:  2019-06-26       Impact factor: 17.425

4.  Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.

Authors:  Russell Rosenblatt; Shirley Cohen-Mekelburg; Nicole Shen; Zaid Tafesh; Catherine Lucero; Sonal Kumar; Brett Fortune; Sze Yan Liu; Robert Brown; Arun Jesudian
Journal:  Am J Gastroenterol       Date:  2019-09       Impact factor: 10.864

5.  β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Càndid Villanueva; Agustín Albillos; Joan Genescà; Joan C Garcia-Pagan; José L Calleja; Carles Aracil; Rafael Bañares; Rosa M Morillas; María Poca; Beatriz Peñas; Salvador Augustin; Juan G Abraldes; Edilmar Alvarado; Ferran Torres; Jaume Bosch
Journal:  Lancet       Date:  2019-03-22       Impact factor: 79.321

6.  A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis.

Authors:  Elliot B Tapper; Daniel Finkelstein; Murray A Mittleman; Gail Piatkowski; Matthew Chang; Michelle Lai
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

7.  Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis.

Authors:  Jessica L Mellinger; Anne Fernandez; Kerby Shedden; G Scott Winder; Robert J Fontana; Michael L Volk; Frederic C Blow; Anna S F Lok
Journal:  Alcohol Clin Exp Res       Date:  2019-01-22       Impact factor: 3.455

8.  Evaluation Within 30 Days of Referral for Liver Transplantation is Associated with Reduced Mortality: A Multicenter Analysis of Patients Referred Within the VA Health System.

Authors:  Binu V John; Kaley Schwartz; Andrew R Scheinberg; Bassam Dahman; Seth Spector; Yangyang Deng; David Goldberg; Paul Martin; Tamar H Taddei; David E Kaplan
Journal:  Transplantation       Date:  2022-01-01       Impact factor: 5.385

9.  Randomised controlled trial of a theory-based intervention to prompt front-line staff to take up the seasonal influenza vaccine.

Authors:  Kelly Ann Schmidtke; Peter G Nightingale; Katharine Reeves; Suzy Gallier; Ivo Vlaev; Samuel I Watson; Richard J Lilford
Journal:  BMJ Qual Saf       Date:  2019-08-05       Impact factor: 7.035

View more
  2 in total

1.  An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.

Authors:  Jeremy Louissaint; Katie Grzyb; Linda Bashaw; Rima A Mohammad; Neehar D Parikh; Elliot B Tapper
Journal:  Am J Gastroenterol       Date:  2022-03-01       Impact factor: 12.045

Review 2.  Review article: current and emerging therapies for the management of cirrhosis and its complications.

Authors:  Elliot B Tapper; Nneka N Ufere; Daniel Q Huang; Rohit Loomba
Journal:  Aliment Pharmacol Ther       Date:  2022-03-02       Impact factor: 9.524

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.